SCHEMBL10314922

SCHEMBL10314922

CCOc1ccc2c(n1)C(=O)NCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.40
PIM2 Q9P1W9 1/20 0.40
BTK Q06187 1/20 0.39
PARP10 Q53GL7 7/20 0.39
PARP1 P09874 6/20 0.39
CYP1A2 P05177 1/20 0.37
GRM5 P41594 1/20 0.37
KCNH2 Q12809 2/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
PARP11 Q9NR21 2/20 0.36
PDPK1 O15530 1/20 0.36
S1PR1 P21453 1/20 0.36
F7 P08709 1/20 0.36
F3 P13726 1/20 0.36
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
IDH1 O75874 1/20 0.35
CYP19A1 P11511 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13064876 0.78 S1PR1 (0.38) PIM1PIM2BTKGRM5KCNH2
SCHEMBL10314900 0.77 GRM5 (0.59) PIM1PIM2BTKPARP10CYP1A2
SCHEMBL10286602 0.76 GPR174 (0.35) BTKADORA2AADORA1MAPK1
SCHEMBL30527082 0.75 MAOA (0.48)
SCHEMBL10272538 0.74 PARP10 (0.49) PIM1PARP10PARP1GRM5PARP11
Hydrochloric Acid SCHEMBL30527058 0.74 MAOA (0.47)
SCHEMBL25217173 0.71 PARP10 (0.49) PIM1PIM2PARP10PARP1GRM5
SCHEMBL29363791 0.71 PARP10 (0.49) PIM1PIM2PARP10PARP1GRM5
SCHEMBL18237666 0.71 PARP10 (0.41) PIM1PIM2PARP10PARP1PARP11
SCHEMBL31058018 0.71 PARP10 (0.39) PARP10PARP1PARP11PDPK1F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853237-B2 Naphthyridinone analogs as mGluR5 positive allosteric modulators VANDERBILT UNIVERSITY (US) 2014-10-07 US disclosed
US-20120172391-A1 NAPHTHYRIDINONE ANALOGS AS MGLUR5 POSITIVE ALLOSTERIC MODULATORS NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172391-A1 NAPHTHYRIDINONE ANALOGS AS MGLUR5 POSITIVE ALLOSTERIC MODULATORS GRM5, GRIK5, GRM1 PIM1 3336/4885PIM2 3337/4885BTK 4251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.